BidaskClub downgraded shares of Walgreens Boots Alliance (NASDAQ:WBA) from a hold rating to a sell rating in a report published on Tuesday, April 10th.
Several other analysts have also issued reports on the company. Vetr raised Walgreens Boots Alliance from a buy rating to a strong-buy rating in a report on Tuesday, December 12th. SunTrust Banks set a $80.00 price target on Walgreens Boots Alliance and gave the company a hold rating in a report on Thursday, December 21st. Zacks Investment Research raised Walgreens Boots Alliance from a hold rating to a buy rating and set a $81.00 price target for the company in a report on Wednesday, December 27th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a buy rating in a report on Wednesday, January 3rd. Finally, Evercore ISI began coverage on Walgreens Boots Alliance in a report on Thursday, January 4th. They set an outperform rating and a $80.00 price target for the company. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Walgreens Boots Alliance has a consensus rating of Buy and a consensus price target of $83.20.
Shares of WBA traded down $0.28 during trading hours on Tuesday, hitting $65.94. The stock had a trading volume of 4,579,733 shares, compared to its average volume of 5,895,117. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45. Walgreens Boots Alliance has a 12 month low of $61.74 and a 12 month high of $87.79. The firm has a market capitalization of $63,288.10, a P/E ratio of 12.93, a PEG ratio of 1.03 and a beta of 1.16.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. During the same quarter in the previous year, the company posted $1.36 earnings per share. Walgreens Boots Alliance’s revenue was up 12.1% compared to the same quarter last year. analysts expect that Walgreens Boots Alliance will post 5.95 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 2.43%. Walgreens Boots Alliance’s payout ratio is 31.37%.
Institutional investors have recently made changes to their positions in the company. Zions Bancorporation grew its stake in Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares in the last quarter. Financial Advocates Investment Management bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $125,000. Fieldpoint Private Securities LLC boosted its position in Walgreens Boots Alliance by 428.6% during the 4th quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock valued at $134,000 after acquiring an additional 1,500 shares in the last quarter. Trustcore Financial Services LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $155,000. Finally, American Research & Management Co. boosted its position in Walgreens Boots Alliance by 271.8% during the 4th quarter. American Research & Management Co. now owns 2,231 shares of the pharmacy operator’s stock valued at $162,000 after acquiring an additional 1,631 shares in the last quarter. Institutional investors and hedge funds own 60.90% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.